AEON icon

AEON Biopharma

81 hedge funds and large institutions have $222M invested in AEON Biopharma in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$3.43M
2 -$491K
3 -$470K
4
OCAM
Owl Creek Asset Management
New York
-$245K
5
Citigroup
Citigroup
New York
-$245K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$602K
52
$563K
53
$517K
54
$505K
55
$503K
56
$493K
57
$493K
58
$489K
59
$469K
60
$395K
61
$394K
62
$392K
63
$368K
64
$363K
65
$302K
66
$246K
67
$246K
68
$243K
69
$243K
70
$221K
71
$219K
72
$203K
73
$186K
74
$165K
75
$145K